NBIX vs. HIMS
Compare and contrast key facts about Neurocrine Biosciences, Inc. (NBIX) and Hims & Hers Health, Inc. (HIMS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NBIX or HIMS.
Correlation
The correlation between NBIX and HIMS is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NBIX vs. HIMS - Performance Comparison
Key characteristics
NBIX:
-0.58
HIMS:
1.09
NBIX:
-0.54
HIMS:
1.89
NBIX:
0.91
HIMS:
1.25
NBIX:
-0.55
HIMS:
1.84
NBIX:
-1.34
HIMS:
4.19
NBIX:
17.72%
HIMS:
27.36%
NBIX:
40.94%
HIMS:
105.11%
NBIX:
-97.21%
HIMS:
-87.29%
NBIX:
-33.86%
HIMS:
-60.39%
Fundamentals
NBIX:
$10.03B
HIMS:
$5.99B
NBIX:
$3.29
HIMS:
$0.54
NBIX:
30.81
HIMS:
50.43
NBIX:
0.27
HIMS:
2.57
NBIX:
4.26
HIMS:
4.06
NBIX:
3.82
HIMS:
12.69
NBIX:
$1.84B
HIMS:
$1.20B
NBIX:
$1.81B
HIMS:
$902.59M
NBIX:
$498.60M
HIMS:
$60.03M
Returns By Period
In the year-to-date period, NBIX achieves a -25.73% return, which is significantly lower than HIMS's 12.61% return.
NBIX
-25.73%
-8.10%
-14.09%
-23.51%
0.49%
8.81%
HIMS
12.61%
-19.63%
22.93%
120.66%
22.71%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NBIX vs. HIMS — Risk-Adjusted Performance Rank
NBIX
HIMS
NBIX vs. HIMS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Neurocrine Biosciences, Inc. (NBIX) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NBIX vs. HIMS - Dividend Comparison
Neither NBIX nor HIMS has paid dividends to shareholders.
Drawdowns
NBIX vs. HIMS - Drawdown Comparison
The maximum NBIX drawdown since its inception was -97.21%, which is greater than HIMS's maximum drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for NBIX and HIMS. For additional features, visit the drawdowns tool.
Volatility
NBIX vs. HIMS - Volatility Comparison
The current volatility for Neurocrine Biosciences, Inc. (NBIX) is 17.47%, while Hims & Hers Health, Inc. (HIMS) has a volatility of 31.11%. This indicates that NBIX experiences smaller price fluctuations and is considered to be less risky than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NBIX vs. HIMS - Financials Comparison
This section allows you to compare key financial metrics between Neurocrine Biosciences, Inc. and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities